Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs for Moderate and Severe Bronchopulmonary Dysplasia
NCT03601416Phase 2Unknown
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Jul 2019
- Primary completion
- Jun 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in bronchopulmonary dysplasia (BPD), sponsored by Children's Hospital of Chongqing Medical University. Status: unknown.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT03601416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03601416.